In melanoma, it has been observed that a loss of β-catenin expression occurs with melanoma progression and that nuclear β-catenin levels are inversely proportional to cellular proliferation as measured by Ki67 staining [16–20]. This evidence concerns the gene MKI67 and melanoma.